Adolescent refractive errors continue to escalate globally, presenting an urgent challenge for modern healthcare systems. Recent clinical investigations indicate that metabolic dysfunction might play a pivotal role in ocular elongation. Specifically, novel evidence links METS-IR and adolescent myopia, revealing that systemic insulin sensitivity directly influences refractive status. Consequently, pediatricians and ophthalmologists must examine metabolic health alongside traditional environmental factors like digital screen time and limited outdoor exposure. By evaluating metabolic surrogates, clinicians can identify vulnerable youths early and introduce multidisciplinary interventions.

Understanding METS-IR and Adolescent Myopia

The metabolic score for insulin resistance, known as METS-IR, provides an accessible and validated surrogate for tissue insulin sensitivity. Researchers derive this metric using fasting blood glucose, fasting triglycerides, body mass index, and high-density lipoprotein cholesterol. Therefore, it circumvents the substantial logistical costs and procedural complexities associated with hyperinsulinemic-euglycemic clamp testing. Traditionally, clinicians associated insulin resistance primarily with cardiometabolic diseases such as type 2 diabetes, non-alcoholic fatty liver disease, and hypertension. However, contemporary ocular science increasingly recognizes the eye as a metabolically active organ sensitive to systemic hormonal fluctuations. Insulin resistance induces chronic low-grade inflammation, endothelial dysfunction, and aberrant growth factor signaling. Furthermore, dysregulated insulin signaling alters scleral extracellular matrix remodeling, accelerating axial elongation during rapid adolescent development. When metabolic dysregulation occurs during pubertal growth spurts, ocular tissues face structural stress. Consequently, assessing METS-IR provides clinicians with crucial systemic context that standard visual acuity examinations cannot capture alone. Understanding these interconnected physiological networks allows practitioners to reframe visual health as an integral component of whole-body metabolic wellness.

Key Findings from the NHANES and Validation Cohorts

To evaluate this systemic connection, investigators examined cross-sectional epidemiological data from 3,946 adolescents aged 12 to 19 years within NHANES. Additionally, they evaluated a complementary, independent cohort comprising 561 East Chinese adolescents to validate the initial findings. The researchers defined myopia as a spherical equivalent of -0.5 diopters or less. Notably, myopic adolescents in the NHANES cohort demonstrated significantly higher METS-IR values compared to non-myopic peers, averaging 32.1 versus 31.3. After adjusting for potential confounding variables, adolescents with elevated METS-IR above 31.84 exhibited a 17% higher likelihood of developing myopia. Furthermore, restricted cubic spline models revealed a clear linear dose-response relationship, establishing an exploratory reference threshold of 31.67. Crucially, the independent validation cohort corroborated these findings, demonstrating an adjusted 13% increased odds of myopia per unit increase. Moreover, this association persisted even after controlling rigorously for parental myopia, which represents a dominant genetic predictor. Hence, the cross-ethnic validation strongly affirms that the metabolic association operates independently of common genetic and demographic confounders.

Biological Synergy Between Insulin Resistance and Obesity

A central observation from this research involves the significant statistical interaction detected between METS-IR and adolescent obesity. In particular, the association between elevated insulin resistance and refractive error became substantially stronger among participants living with obesity. Because METS-IR incorporates body mass index directly into its calculation, the investigators conducted rigorous sensitivity analyses to isolate true biological synergy. Specifically, they analyzed individual biochemical components and evaluated the body mass index-independent triglyceride-glucose index. As expected, these sensitivity analyses confirmed that excessive adiposity actively amplifies the adverse visual impact of metabolic dysregulation. Adipose tissue functions as an active endocrine organ that secretes pro-inflammatory adipokines and systemic cytokines. When obesity coexists with hyperinsulinemia, circulating inflammatory mediators surge, aggravating vascular endothelial permeability and ocular microcirculation. Furthermore, altered insulin-like growth factor signaling pathways accelerate connective tissue turnover within the posterior eye cup. Therefore, the combination of adiposity and insulin resistance creates a permissive biochemical environment that expedites scleral stretch. These findings confirm that obesity and insulin resistance interact synergistically rather than acting merely as redundant risk markers.

Pathophysiological Links Between Metabolism and Eye Growth

How does systemic insulin resistance promote axial elongation and refractive shifts? Biologically, chronic hyperinsulinemia reduces hepatic production of insulin-like growth factor binding proteins, thereby elevating bioavailable insulin-like growth factor 1. Because ocular tissues express high densities of these growth factor receptors, excess signaling promotes matrix metalloproteinase production. Consequently, increased enzymatic activity degrades scleral collagen fibers, which decreases tissue stiffness and facilitates pathological ocular elongation. Additionally, metabolic dysregulation induces localized hypoxia and oxidative stress within the choriocapillaris, impairing nutritional support to outer retinal layers. Such microvascular compromise alters the secretion of dopamine and transforming growth factor-beta, both of which govern emmetropization. Hyperglycemia and lipid peroxidation also stimulate advanced glycation end-product accumulation across ocular structures, altering biomechanical properties of the sclera. In contrast, balanced metabolic homeostasis preserves collagen cross-linking and maintains structural scleral integrity against mechanical distension. Thus, metabolic dysregulation directly transforms the scleral microenvironment from stable scaffolding into malleable connective tissue prone to axial stretching.

Clinical Implications for Pediatric and Ophthalmic Practice

These epidemiological insights offer tangible opportunities for modern interdisciplinary practice. Traditionally, eye care professionals approached myopia management through optical corrections, atropine eye drops, and orthokeratology lenses. Meanwhile, pediatricians independently managed metabolic indicators and dietary lifestyle habits. However, integrating METS-IR assessment creates a unified pathway where ocular health and cardiometabolic wellness reinforce each other. Routine pediatric health examinations can readily compute METS-IR from standard fasting blood lipid panels and routine anthropometric metrics. If an adolescent exhibits borderline or elevated values exceeding 31.67, clinicians should recommend comprehensive ophthalmic surveillance. Similarly, optometrists and ophthalmologists observing rapid axial length progression should screen for underlying metabolic irregularities, especially in overweight youths. Nutritional counseling that restricts refined carbohydrates and ultra-processed foods can mitigate hyperinsulinemia while dampening myopia triggers. Furthermore, encouraging outdoor physical activity delivers dual benefits by promoting natural retinal dopamine release and improving peripheral insulin sensitivity. Ultimately, adopting a collaborative care model will enhance preventive pediatric medicine and curb progressive vision loss across diverse patient populations.

Frequently Asked Questions

What is METS-IR and how is it calculated in adolescents?

The Metabolic Score for Insulin Resistance, or METS-IR, serves as a validated, non-insulin-based surrogate for tissue insulin sensitivity. Clinicians calculate this score using routine clinical parameters, including fasting blood glucose, triglycerides, high-density lipoprotein cholesterol, and body mass index. Because it avoids costly insulin assays, METS-IR offers an affordable and practical tool for screening cardiometabolic and refractive risks. Consequently, primary care providers can seamlessly incorporate it into annual adolescent health checks.

Why does adolescent obesity amplify the visual risk linked with insulin resistance?

Adolescent obesity amplifies refractive risk through biological synergy with hyperinsulinemia. Adipose tissue functions as an active endocrine organ that releases pro-inflammatory adipokines and cytokines. Concurrently, elevated insulin levels decrease protective insulin-like growth factor binding proteins, increasing active growth factor signaling. Together, systemic inflammation and elevated growth factors disrupt scleral extracellular matrix integrity, accelerating axial elongation. Therefore, combining excess adiposity with metabolic dysfunction creates a permissive biological state for rapid myopic progression.

How should clinicians apply METS-IR findings in everyday clinical practice?

Clinicians should adopt a collaborative approach combining metabolic assessment with visual health tracking. Pediatricians identifying high METS-IR scores or childhood obesity should schedule regular cycloplegic refractive screenings and axial length monitoring. Conversely, eye care professionals treating rapid myopic progression should inquire about dietary habits, sedentary behaviors, and metabolic history. Recommending low-glycemic nutrition, reduced screen time, and daily outdoor physical activity simultaneously improves systemic insulin sensitivity and curbs abnormal axial ocular elongation.

Disclaimer: This content is for informational and educational purposes only... Refer to the latest local and national guidelines for clinical practice.

References

1. Huang Y et al. Metabolic score for insulin resistance is associated with myopia in adolescents: A cross-sectional study with a complementary independent cohort. J Formos Med Assoc. 2026 Sep 12. doi: undefined. PMID: 42731939.
2. Morgan IG, French AN, Ashby RS, et al. The epidemics of myopia: Aetiology and prevention. Prog Retin Eye Res. 2018;62:134-149.
3. Bello-Chavolla OY, Almeda-Valdes P, Gomez-Velasco D, et al. METS-IR, a novel score to evaluate insulin sensitivity, is predictive of visceral adiposity and incident type 2 diabetes. Eur J Endocrinol. 2018;178(5):533-544.